Searchable abstracts of presentations at key conferences in endocrinology

ea0049d6.2 | Is it time for initial combination in type 2 diabetes? | ECE2017

Is it time for initial combination in type 2 diabetes? - AGAINST

Mauricio Didac

Type 2 diabetes mellitus is a heterogeneous disease with multiple pathophysiological pathways contributing to hyperglycemia, and also resulting in a variable clinical picture. Thus, individualization of hypoglycemic therapy is a mainstay of current clinical guidelines. Several factors should be considered for a given treatment choice. These include the characteristics related to a given medication (efficacy, hypoglycemia, effect on weight, other safety issues, the mechanism of...

ea0073s18.1 | Symposium 18: The future of endocrinology Artificial Intelligence (AI) and big data! | ECE2021

AI in the clinical setting

Mauricio Didac

There are different activities related to health care that are currently generating a large amount of data. Real-world evidence studies are becoming an important source of information that complements the one produced through other sources of evidence. On top of this, current knowledge in the field of massive data analysis allows processing of these data to produce relevant information that will eventually help clinicians in many aspects of their daily practice, especially reg...

ea0037ep1052 | Thyroid (non-cancer) | ECE2015

Percutaneous ethanol injection as a first line treatment of cystic thyroid nodules: experience after its introduction in a university hospital

Reverter Jordi L , Alonso Nuria , Ordonez Isabel , Cuadrado Maribel , Cano Lucia , Mauricio Didac , Domingo Manel Puig

Objectives: To evaluate the efficacy, safety and patient’s pain perception of percutaneous ethanol injection treatment (PEIT) as an alternative to surgery in symptomatic thyroid cysts.Patients and methods: Thirty consecutive patients (mean age: 46±10 years; 82% women) with symptomatic thyroid cysts relapsed after drainage were included. In all cases, cytology prior to treatment, maximum cyst diameter and volume were determined. PEIT was conduct...

ea0037gp.23.07 | Thyroid – diagnosis | ECE2015

Immunohistochemical tool for the diagnosis of benign and malignant follicular tumours

Castelblanco Esmeralda , Martinez Montserrat , Santos Ma Dolores , Mancikova Veronica , Robledo Mercedes , Matias-Guiu Xavier , Maravall Javier , Mauricio Didac

Introduction: Follicular tumours of the thyroid gland include benign follicular adenomas, follicular carcinomas and the follicular variant of papillary carcinoma. Although, molecular markers are a promising area of research to differentiate thyroid neoplasms, there is ample room for improvement in the research and clinical applications in this field. Furthermore, the final diagnosis requires thyroid lobectomy. The present study examined whether a differential protein expressio...

ea0035p1095 | Thyroid Cancer | ECE2014

Differential miRNAs expression in papillary thyroid cancer is associated with clinico-pathological features and BRAF mutation

Castelblanco Esmeralda , Rosado Veronica , Martinez Montserrat , Santos Maria Dolores , Mancikova Veronica , Robledo Mercedes , Matias-Guiu Xavier , Maravall Javier , Mauricio Didac

Introduction: MicroRNAs (miRNAs) are short non-coding RNAs that regulate translation or degradation of target mRNAs. Therefore, miRNAs control gene expression in many biological processes, including proliferation, apoptosis, and differentiation. Deregulation of miRNAs expression is an important contributor to tumour development and progression. Even though several genetic and epigenetic lesions have been identified in human thyroid cancer, particularly in the papillary histoty...

ea0056p449 | Diabetes complications | ECE2018

Type 1 diabetes is associated with a differential pattern of carotid atherosclerotic plaque types

Castelblanco Esmeralda , Ramirez-Morros Anna , Hernandez Marta , Granado Minerva , Betriu Angels , Puig-Domingo Manel , Alonso Nuria , Mauricio Didac

Introduction: The presence and type of atherosclerotic plaque is associated with future cardiovascular events (CVE). We previously described that increased frequency of plaques is associated with specific features in type 1 diabetes. The aim of the present study was to investigate the characteristics of atherosclerotic plaques in patients with type 1 diabetes mellitus (T1D).Methods: A cross-sectional study of 174 subjects with carotid atherosclerotic pla...

ea0056p464 | Diabetes complications | ECE2018

Subclinical atheromatous disease detection improves cardiovascular event prediction in chronic kidney disease with and without diabetes

Palanca Ana , Castelblanco Esmeralda , Betriu Angels , Valdivielso Jose M , Perpinan Hector , Puig-Domingo Manel , Fernandez Elvira , Mauricio Didac , Alonso Nuria

Background: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in chronic kidney disease (CKD) patients with and without diabetes mellitus (DM). Traditional cardiovascular risk factors fail to fully account for the increase in cardiovascular risk in these patients. The NEFRONA study is a large, multicentre, prospective, observational study that evaluated atheromatous disease (AD) in the carotid and femoral territories in a large cohort of Spanish CKD ...

ea0049gp84 | Diabetes & complications 2 | ECE2017

Antidiabetic medication use and the risk of fracture in type 2 diabetic patients: a nested case-control study

Losada Eladio , Soldevila Berta , Ali M. Sanni , Martinez-Laguna Daniel , Nogues Xavier , Diez-Perez Adolfo , Puig-Domingo Manel , Mauricio Didac , Prieto-Alhambra Daniel

Background: Patients with type 2 diabetes mellitus (T2DM) have an increased risk of fragility fractures. Anti-diabetic oral agents and insulin may also impact on fracture risk. There is however scarce data available on the effect of such therapies combined as usually prescribed in real-life practice conditions.Objectives: The objective of this study was to compare the risk of fracture among T2DM patients who are users of different antidiabetic treatments...

ea0056gp101 | Diabetes Therapy | ECE2018

A healthier fat intake is associated with absence of diabetic retinopathy in patients with type 1 diabetes

Granado-Casas Minerva , Martin Mariona , Real Jordi , Ramirez-Morros Anna , Castelblanco Esmeralda , Alonso Nuria , Traveset Alicia , Alcubierre Nuria , Puig-Domingo Manel , Hernandez Marta , Mauricio Didac

Background: Medical nutrition therapy is an important part of the management of type 1 diabetes mellitus (T1DM). Proper adherence to a healthy diet may have a favorable impact on diabetic complications. Our aim was to assess differences in food and nutrient intake of type 1 diabetic patients with and without diabetic retinopathy (DR).Subjects and methods: This was a two-center, cross-sectional study in patients diagnosed with T1DM with and without DR. Su...

ea0056gp257 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

Impact of TSH during the first trimester of pregnancy in obstetric and fetal complications: Usefulness of 2.5 mIU/l cut-off value

Soldevila Berta , Hernandez Marta , Lopez Carolina , Cacenarro Laura , Martinez-Barahona Maria , Palomera Elisabet , Rius Ferran , Lecube Albert , Pelegay Maria Jose , Garcia Jordi , Mauricio Didac , Puig-Domingo Manel

Background: An association of pregnancy outcomes with subclinical hypothyroidism have been reported, however, there still exists a strong controversy regarding whether subclinical hypothyroidism ought to be dealt with or not. The latest American Thyroid Association’s guideline gives support to a higher TSH upper reference range of 4 mIU/l than the one proposed a few years ago of 2.5 mIU/l for the first trimester of pregnancy, in the absence of local normal ranges of TSH. ...